Discovery fills gap in search for better treatments for Ebola, other viruses

March 7, 2018 by Lesley Young, University of Alberta
The Ebola virus, isolated in November 2014 from patient blood samples obtained in Mali. The virus was isolated on Vero cells in a BSL-4 suite at Rocky Mountain Laboratories. Credit: NIAID

University of Alberta researchers have found the Ebola polymerase (enzyme), which may lead to more effective research and better treatments for the often fatal infection, and other related viral diseases.

"Our study reports the expression, purification and biochemical characterization of an active, recombinant EBOV complex that is responsible for the propagation of the Ebola virus. It will give researchers worldwide the tool they need to study Ebola inhibitors in any lab environment.

"Until now, research with the Ebola virus has been largely limited to a few extreme biosafety labs," explained lead author Matthias Götte, professor and chair of the U of A's Department of Medical Microbiology & Immunology and a member of the Li Ka Shing Institute of Virology.

"These labs were not unlike what you've seen in Hollywood movies like Outbreak," he said.

The discovery should also allow researchers to better search for antiviral medicines for viruses that don't currently have effective treatments but are major public health risks, such as influenza, measles, mumps and (RSV).

"Our discovery is not an actual cure for these diseases, but rather fills a major gap that existed in the search for treatments. The hope is that it accelerates further research into medicines, such as polymerase inhibitors, that will help to save lives," said Götte.

The last Ebola outbreak in 2014 in West Africa took 11,000 lives. It required a massive international effort to minimize and eventually contain the spread of the disease.

"Ebola is a very serious threat that is not limited by borders," added Götte.

Persistence behind discovery

"Isolating the RNA polymerase has proven to be a challenge for so many researchers simply because it is a difficult protein to produce in the lab," explained Götte.

More than two years ago, Götte and his team set out to look for other protocols related to the enzyme.

"While there has been progress in producing related enzymes in other labs, there was no unifying protocol. So really, it was a case of trial and error," he said.

The difficulty is not only in creating and purifying the protein, but also in developing an assay to show that the protein is active, he added.

"The first time we yielded an active polymerase for the Ebola in the lab, we couldn't believe it. Then we ran many controlled experiments to see if it was real. It was an exciting time."

The study was published in Scientific Reports.

Explore further: Ebola virus infects reproductive organs in monkeys

More information: Egor P. Tchesnokov et al. Recombinant RNA-Dependent RNA Polymerase Complex of Ebola Virus, Scientific Reports (2018). DOI: 10.1038/s41598-018-22328-3

Related Stories

Ebola virus infects reproductive organs in monkeys

February 8, 2018
Ebola virus can infect the reproductive organs of male and female macaques, according to a study published in The American Journal of Pathology, suggesting that humans could be similarly infected. Prior studies of survivors ...

Ebola virus exploits host enzyme for efficient entry to target cells

February 7, 2018
Researchers have identified a key process that enables the deadly Ebola virus to infect host cells, providing a novel target for developing antiviral drugs. The Ebola virus incorporates a cellular enzyme into its virus particles, ...

Researchers inhibit Ebola virus

December 29, 2017
The incurable Ebola virus has long been feared due to its high mortality rate and danger of infection. Now researchers from the University of Copenhagen and Phillips Universität Marburg have succeeded in inhibiting the virus ...

Societal challenges and new treatments for Ebola virus disease

July 6, 2015
Since Ebola was first described in 1976, there have been several outbreaks, but all have been self-limiting. In a new Journal of Internal Medicine review, Dr. Ali Mirazimi of the Karolinska Institutet considers why the latest ...

Potential evidence of lung-specific Ebola infection found in recovering patient

January 5, 2017
Scientists have found potential evidence of Ebola virus replication in the lungs of a person recovering from infection, according to new research published in PLOS Pathogens. The findings could aid research into new treatment ...

Researchers find possible explanation for unparalleled spread of Ebola virus

June 7, 2017
The world may be closer to knowing why Ebola spreads so easily thanks to a team of researchers from Tulane University and other leading institutions who discovered a new biological activity in a small protein from the deadly ...

Recommended for you

Taking the virus out of a mosquito's bite

December 12, 2018
They approach with the telltale sign—a high-pitched whine. It's a warning that you are a mosquito's next meal. But that mosquito might carry a virus, and now the virus is in you. Now, with the help of state-of-the-art technology, ...

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

Human antibody discovery could save lives from fungal killer

December 11, 2018
A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.

Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism

December 11, 2018
Treatment with active vitamin D did not decrease cardiovascular events in kidney patients undergoing hemodialysis, according to a research group in Japan. They have reported their research results in the December 11 issue ...

Dialysis patients at risk of progressive brain injury

December 10, 2018
Kidney dialysis can cause short-term 'cerebral stunning' and may be associated with progressive brain injury in those who receive the treatment for many years. For many patients with kidney failure awaiting a kidney transplant ...

Silicosis is on the rise, but is there a therapeutic target?

December 6, 2018
Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.